Genetic Mechanisms of Arteriosclerosis in Hypertensive Sibships
Genetic Mechanisms of Arteriosclerosis in Hypertensive Sibships
批准号:
8918019
负责人:
Sharon L Kardia
金额:
$67.58万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2018-06-30
关键词:
African AmericanAnkleArterial DisorderArteriesArteriolosclerosesArteriosclerosisAtherosclerosisBiologicalBlood PressureBrainCardiacCerebrumChronic Kidney FailureClinicalCommunitiesDNA SequenceDNA Sequence AlterationDataDementiaDiseaseEpidemiologyExonsFamilyGene ExpressionGenerationsGenesGeneticGenetic RiskGenetic VariationGenetic studyGenomeGenomic SegmentGenomicsHealthHealth Care CostsHeartHeart failureHypertensionIndividualIschemic Brain InjuryKidneyKidney DiseasesLegMeasuresMethodsMyocardial InfarctionNot Hispanic or LatinoOrganOutcomeParticipantPeripheralPopulationPopulation Attributable RisksPredispositionRiskRisk FactorsSamplingStrokeTimeUnited StatesVariantbasebody systemclaudicationcohortcoronary artery calcificationcost effectivedesignexomefamilial hypertensiongenetic epidemiologygenetic variantgenomic variationhigh riskindexingrare variantrisk varianttranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Genetic Epidemiology Network of Arteriopathy (GENOA) was initiated in 1995 to study the genetics of hypertension and its arteriosclerotic complications in sibships. Arteriosclerosis (i.e., atherosclerosis and arteriolosclerosis) of the cardiac, cerebral, renal, and peripheral arteries leads to target organ damage and clinical sequelae such as heart attack, heart failure, stroke, dementia, chronic kidney disease, and claudication. In this application, we propose to conduct an exome-wide association study (Aim 1) and transcriptomic profiling (Aim 2) as cost-effective methods of identifying and studying functional variations in the 1020 GENOA African-American and non-Hispanic White sibships (N=2912) who are at high risk of developing a wide range of arteriosclerotic clinical outcomes. The GENOA cohort provides a unique opportunity to assess the phenotypic impact of rare variants that naturally replicate within a sibship, but may not be seen again even in large epidemiological populations. The GENOA community-based sampling of hypertensive sibships was explicitly designed to study the genetics of multiple late-onset arteriosclerotic diseases that
typically become clinically apparent only in the upper generations of families. In order to ultimately identify "at risk" individuals and estimate the cumulative burden of genetic risk allele in two U.S. populations (Aim 3) we will estimate genetic risk scores and assess the attributable fraction of phenotypic variation explained by these new genetic variations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study in India (LASI) Genomic Study-Covid-19 Administrative Supplement Year 2
-
批准号:10309409
-
项目类别:
-
资助金额:$40.64万
-
财政年份:2019
-
负责人:Sharon L Kardia
-
依托单位:
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study
-
批准号:10836795
-
项目类别:
-
资助金额:$38.64万
-
财政年份:2019
-
负责人:Sharon L Kardia
-
依托单位:
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study.
-
批准号:10017825
-
项目类别:
-
资助金额:$350.35万
-
财政年份:2019
-
负责人:Sharon L Kardia
-
依托单位:
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study.
-
批准号:10237323
-
项目类别:
-
资助金额:$146.42万
-
财政年份:2019
-
负责人:Sharon L Kardia
-
依托单位:
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study.
-
批准号:10685990
-
项目类别:
-
资助金额:$165.2万
-
财政年份:2019
-
负责人:Sharon L Kardia
-
依托单位:
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study.
-
批准号:10474359
-
项目类别:
-
资助金额:$165.2万
-
财政年份:2019
-
负责人:Sharon L Kardia
-
依托单位:
Genetic Mechanisms of Arteriosclerosis in Hypertensive Sibships
-
批准号:9302511
-
项目类别:
-
资助金额:$31.34万
-
财政年份:2014
-
负责人:Sharon L Kardia
-
依托单位:
Genetic Mechanisms of Arteriosclerosis in Hypertensive Sibships
-
批准号:8758883
-
项目类别:
-
资助金额:$70.05万
-
财政年份:2014
-
负责人:Sharon L Kardia
-
依托单位:
Genetic and Psychosocial Predictors of Blood Pressure and Body Mass Index
-
批准号:8738570
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2013
-
负责人:Sharon L Kardia
-
依托单位:
Genetic and Psychosocial Predictors of Blood Pressure and Body Mass Index
-
批准号:8617892
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2013
-
负责人:Sharon L Kardia
-
依托单位:
Linking Community Engagement Research to Public Health Biobank Practice
-
批准号:8022486
-
项目类别:
-
资助金额:$65.6万
-
财政年份:2010
-
负责人:Sharon L Kardia
-
依托单位:
Linking Community Engagement Research to Public Health Biobank Practice
-
批准号:8597449
-
项目类别:
-
资助金额:$59.01万
-
财政年份:2010
-
负责人:Sharon L Kardia
-
依托单位:
Linking Community Engagement Research to Public Health Biobank Practice
-
批准号:8391714
-
项目类别:
-
资助金额:$56.92万
-
财政年份:2010
-
负责人:Sharon L Kardia
-
依托单位:
Linking Community Engagement Research to Public Health Biobank Practice
-
批准号:8208039
-
项目类别:
-
资助金额:$61.3万
-
财政年份:2010
-
负责人:Sharon L Kardia
-
依托单位:
Epigenetic Biomarkers of Common Chronic Diseases
-
批准号:7936366
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Sharon L Kardia
-
依托单位:
Informed Consent and Data Access Issues in State-based Biobanks
-
批准号:7940959
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2009
-
负责人:Sharon L Kardia
-
依托单位:
Epigenetic Biomarkers of Common Chronic Diseases
-
批准号:7829431
-
项目类别:
-
资助金额:$49.87万
-
财政年份:2009
-
负责人:Sharon L Kardia
-
依托单位:
Informed Consent and Data Access Issues in State-based Biobanks
-
批准号:7833333
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2009
-
负责人:Sharon L Kardia
-
依托单位:
Genomic Predictors of Arteriosclerosis in Hypertensives
-
批准号:7642391
-
项目类别:
-
资助金额:$104.15万
-
财政年份:2007
-
负责人:Sharon L Kardia
-
依托单位:
Core--Biostatistics
-
批准号:7338021
-
项目类别:
-
资助金额:$15.72万
-
财政年份:2007
-
负责人:Sharon L Kardia
-
依托单位:
国内基金
海外基金
ANKLE2通过调控PINK1减轻脓毒症心肌细胞线粒体钙超载的机制研究
-
批准号:CSTB2023NSCQ-MSX0603
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:许皓
-
依托单位:
影响核膜与内质网膜结构的ANKLE2分子在衰老调控中的关键作用
-
批准号:91649107
-
项目类别:重大研究计划
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:朱正茂
-
依托单位: